CDK5RAP3 and hepatocellular carcinoma: In contrast, additional studies indicate that CDK5RAP3 appears to promote tumorigenesis because it is overexpressed in lung adenocarcinoma (29), hepatocellular carcinoma (11, 14), breast cancer (17) and cervical carcinoma (30), and has an oncogenic roles in these cancers.